Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Seecure Taiwan Co. Ltd. is engaged in the Biotechnology & Pharmaceuticals technology area. The company currently has 1 pending office action. This single matter is being examined by 1 distinct examiner, DONOHUE, SEAN R, within 1 distinct art unit. DONOHUE, SEAN R is the busiest examiner with 1 busiest examiner pending. This means the company's current prosecution efforts are entirely focused on a single examiner. The use of 1 distinct art unit indicates that the pending intellectual property is specialized.
With only 1 pending office action, the company has a very narrow prosecution footprint. Practitioners should carefully manage the relationship with the 1 distinct examiner to ensure the best possible results for this single active case. The absence of multiple examiner perspectives means there is no internal baseline for comparing examiner behavior. Every interaction with DONOHUE, SEAN R is critical, as there are no other active matters to balance the portfolio's progress. This concentration means that the company's immediate patent prospects are shaped by a single individual's interpretation within the 1 distinct art unit. For a portfolio of this scale, the focus is on a single high-priority application.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DONOHUE, SEAN R | 1 | 41.4% | +21.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17802190 | THIOPURINE-BASED COMPOUND, COMPOSITION, METHOD OF PREPARATION AND APPLICATIONS | DONOHUE, SEAN R | 1d overdue |
| Art Unit | Apps |
|---|---|
| 1618 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17802190 | THIOPURINE-BASED COMPOUND, COMPOSITION, METHOD OF PREPARATION AND APPLICATIONS | DONOHUE, SEAN R | 1618 | §103 | Final Rejection | 1d overdue | Pending | Aug 25, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial